James Music
Family · Martin, KYNPI 1740702257
Payments from drug & device makers
Across 87 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$199
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$156
- Abbott$123
- Boehringer Ingelheim$116
- Pfizer$101
- AstraZeneca$98
- plus $624 from 16 others
What the payments were for
- Food & beverage$1,417100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $199 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $156 |
| Abbott | 7 | $123 |
| Boehringer Ingelheim | 7 | $116 |
| Pfizer | 5 | $101 |
| AstraZeneca | 5 | $98 |
| Kyowa Kirin, Inc. | 3 | $76 |
| Lilly USA, LLC | 5 | $74 |
| Ultragenyx Pharmaceutical Inc. | 4 | $66 |
| Xeris Pharmaceuticals, Inc. | 4 | $63 |
| Amgen | 3 | $50 |
| Corcept Therapeutics | 3 | $49 |
| Verona Pharma, Inc. | 2 | $38 |
| Novo Nordisk | 2 | $36 |
| Novartis | 2 | $33 |
| Bayer | 2 | $30 |
| Gilead | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
How this compares
$1,417 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 137 | $156,479 |
| OzempicSemaglutide | 158 | $141,896 |
| FarxigaDapagliflozin Propanediol | 69 | $52,325 |
| TrulicityDulaglutide | 48 | $45,403 |
| JardianceEmpagliflozin | 56 | $41,652 |
| EliquisApixaban | 48 | $36,347 |
| VascepaIcosapent Ethyl | 60 | $28,892 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $27,131 |
| LinzessLinaclotide | 39 | $22,449 |
| TradjentaLinagliptin | 24 | $17,947 |
| Breo ElliptaFluticasone/Vilanterol | 38 | $16,560 |
| EntrestoSacubitril/Valsartan | 19 | $14,867 |
| JanuviaSitagliptin Phosphate | 21 | $14,695 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $13,606 |
| KerendiaFinerenone | 17 | $13,028 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $74 | $201,882185 claims |
| Novo NordiskOzempic | $36 | $141,896158 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $98 | $65,93188 claims |
| Boehringer IngelheimJardiance, Tradjenta | $116 | $59,60080 claims |
| PfizerEliquis, Premarin | $101 | $41,70261 claims |
| AbbVieLinzess, Creon | $199 | $28,96950 claims |
| NovartisEntresto | $33 | $14,86719 claims |
| BayerKerendia | $30 | $13,02817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.
Other family in Martin
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.